TA
Tatva Chintan Pharma Chem Ltd (TATVA)
₹1,775.30
Mkt cap
₹4,141 Cr
P/E ratio
79.00
P/B
5.32
Div yield
0.11%
ROE
5.54%
ROCE
7.18%
EPS (TTM)
₹22.47
Book value
₹334
52W range
982–1,880
Sector
Commodities
Price history
Previous close
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals [1]
NSE TATVABSE 543321
Health check
Mixed
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBullish
52-week range
−5.57% from high₹1,775
₹982+80.88% from low₹1,880
Current
₹1,775.30
Prev close
₹1,743.20
Day
+1.84%
Price performance
1D
+1.84%
1W
−1.00%
1M
+9.80%
3M
+41.41%
6M
+60.84%
1Y
+68.20%
YTD
+27.83%
Financials
Revenue, profit & margin
P/E ratio
79.0×
TATVA is 174% above the sector median of 28.8×
TATVA79.0×
Sector median28.8×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 114 | 97 | 84 | 98 | 105 | 83 | 86 | 108 | 117 | 124 | 131 | 134 | 167 | |
| Expenses | 93 | 76 | 73 | 83 | 93 | 78 | 79 | 99 | 100 | 101 | 106 | 106 | 135 | |
| Operating Profit | 21 | 20 | 11 | 16 | 13 | 6 | 7 | 9 | 17 | 22 | 25 | 28 | 32 | |
| OPM % | 19% | 21% | 13% | 16% | 12% | 7% | 8% | 8% | 15% | 18% | 19% | 21% | 19% | |
| Other Income | 1 | 1 | 1 | 5 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | -0 | 1 | |
| Interest | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | |
| Depreciation | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 10 | 11 | |
| Profit before tax | 13 | 11 | 5 | 14 | 7 | -1 | -0 | 2 | 9 | 14 | 18 | 17 | 21 | |
| Tax % | 29% | 31% | 34% | 30% | 24% | -34% | -165% | 49% | 27% | 27% | 14% | 38% | 24% | |
| Net Profit | 10 | 8 | 3 | 10 | 5 | -1 | 0 | 1 | 7 | 10 | 15 | 10 | 16 | |
| EPS in Rs | 4.29 | 3.33 | 1.48 | 4.11 | 2.23 | -0.28 | 0.06 | 0.44 | 2.84 | 4.24 | 6.49 | 4.41 | 6.83 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202672.02%Promoter
Promoters72.02%
FIIs3.93%0.12
DIIs3.11%0.12
Public20.94%0.22
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,572.10 | 60.42 | 1,60,021 | 0.73% | 884 | +28.18% | 4,552 | +21.27% | 31.02% |
| Gujarat Fluoroch | ₹4,586.70 | 81.57 | 50,385 | 0.07% | 219 | +21.43% | 1,588 | +23.97% | 9.64% |
| Navin Fluo.Intl. | ₹8,590.00 | 55.42 | 44,079 | 0.18% | 243 | +107.67% | 1,045 | +44.07% | 20.96% |
| Deepak Nitrite | ₹1,586.30 | 27.31 | 21,636 | 0.47% | 345 | +207.50% | 2,578 | +36.39% | 11.37% |
| Aether Industri. | ₹1,630.00 | 90.17 | 21,635 | 0.00% | 63 | +27.98% | 327 | +27.25% | 11.92% |
| Atul | ₹6,170.50 | 22.84 | 18,167 | 0.49% | 254 | +91.99% | 1,848 | +25.03% | 14.90% |
| Aarti Industries | ₹491.15 | 34.11 | 17,815 | 0.20% | 155 | +256.47% | 2,387 | +42.51% | 6.86% |
| Tatva Chintan | ₹1,770.20 | 79.04 | 4,141 | 0.11% | 16 | +155.34% | 167 | +42.96% | 7.18% |
| Median: 94 Co. | ₹338.50 | 28.83 | 1,047 | 0.28% | 13 | +46.09% | 171 | +25.55% | 13.69% |
Filings
Annual reports6
Concall transcripts49
TranscriptJul 2026PPTJul 2026RECJul 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptJan 2026PPTJan 2026RECJan 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptJul 2025PPTJul 2025RECJul 2025TranscriptMay 2025PPTMay 2025TranscriptJan 2025PPTJan 2025TranscriptOct 2024PPTOct 2024TranscriptJul 2024PPTJul 2024RECJul 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17 Sep - Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (LODR) Regulations, 2015.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8 Sep - Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (LODR) Regulations, 2015.Announcement under Regulation 30 (LODR)-Credit Rating 8 Sep - CRISIL upgraded Tatva Chintan’s bank facilities rating to A-/Stable and A2+ for Rs245 crore facilities.Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Aug - Newspaper Advertisement - Disclosure under Regulation 30, 44 and 47 of the SEBI (LODR) Regulations, 2015, as ....Intimation Of Record Date, Book Closure And Cut-Off Date Pursuant To Regulation 42 And 44 Of The SEBI (LODR) Regulations, 2015 (SEBI Listing Regulations) 27 Aug - Book closure 12-25 Sep 2026; record date 11 Sep for final dividend and 30th AGM voting.